Fellowship Mission Statement
As a Personalized Medicine, Compounding, and Research Fellow of Medimix Specialty Pharmacy, you will assemble a portfolio of experiences ranging from medication therapy management to clinical research, positioning you for top level careers in academia, industry, or entrepreneurship. Fellowship directors with highly decorated resumes lead our program which includes product development, clinical research, medication therapy management, teaching opportunities, lectures and presentations, publications, medical communications, sales, and marketing. Upon completion of our fellowship program, you will have an unparalleled resume giving you the competitive edge for any position you wish to pursue.
As a fellow at Medimix,you will be afforded unique opportunities that will develop and prepare you with skills that will help you throughout your career. Our goal at Medimix Specialty Pharmacy is to help you develop the most competitive profile for any sector of pharmacy practice you wish to pursue.
• Learn and execute Medimix’s proprietary 34-step process to product development to create a new compound and then participate in sales and marketing to track the product’s success
• Write and conduct federally registered research on a multitude of topics, including pain management, BHRT, and topical wound therapy
• Form personal and professional relationships with health care providers across the country
• Conduct patient interviews and consultations on a variety of compounded products
• Perform presentations to fellow pharmacists, technicians, and medical providers
• Educate future pharmacists through preceptorship and other teaching opportunities
• Understand the entrepreneurial aspects that allow a business to become successful
For more benefits information on the Personalized Medicine, Compounding, and Fellowship at Medimix Specialty Pharmacy, please email Ben Epstein, Pharm.D. at email@example.com.
About the Fellowship Directors:
Benjamin Epstein, Pharm.D., BCPS
Dr. Epstein completed his Residency and Fellowship at the University of Florida, where he also established a Research Program and Pharmacotherapy Clinic. He later accepted a position as Assistant Professor in the College of Pharmacy with a joint appointment in the College of Medicine. Dr. Epstein has authored articles published in New England Journal of Medicine, Drugs, American Family Physician, Current Opinion on Investigational Drugs, Pharmacotherapy, and Annals of Pharmacotherapy. In 2012, Dr. Epstein leveraged his collective academic and clinical research expertise to launch Medimix Specialty Pharmacy. As co-founder and Chief Medical Officer, he has helped catapult Medimix to the forefront of the industry.
Rushab Choksi, Pharm.D.
From clinical practice, to seven years in pharmaceutical industry, Dr. Choksi brings a strong background in clinical research. With extensive experience in medical affairs at multiple pharmaceutical companies, Dr. Choksi understands all roles from investigators to coordinators. His therapeutic expertise spans a broad range of disease states including cardiology, pulmonary medicine, nephrology, hematology, and primary care. As co-founder of Medimix, Dr. Choksi works closely with the research, sales and marketing teams.
Past & Current Fellows:
Under the direction of Dr. Benjamin Epstein and Dr. Rushab Choksi
Donna Leverone, Pharm.D.
Program Dates: 2009-2010
Currently: Assistant Professor, Temple University College of Pharmacy
Niren Shah, Pharm.D.
Program Dates: 2010-2012
Currently: Medical Science Liaison, Novartis
Marjohn Armoon, Pharm.D.
Program Dates: 2012-2013
Currently: Medical Science Liaison, Johnson and Johnson
Rebecca Rosenwasser, Pharm.D.
Program Dates: 2012-2014
Currently: Director of Clinical Operations, East Coast Institute for Research
Rohit Tahiliani, Pharm.D.
Program Dates: 2013-2014
Currently: Vice President of Clinical Services, Veterinary Compounding
Gregory Koyama, Pharm.D.
Program Dates: 2014-Present
University of the Pacific Thomas J. Long School of Pharmacy & Health Sciences
Jenny Liu, Pharm.D.
Program Dates: 2014-Present
University of Florida College of Pharmacy
Alyse Scaffidi, Pharm.D.
Program Dates: 2014-Present
Rutgers Ernest Mario School of Pharmacy
Areas of Research:
Medimix Specialty Pharmacy is one of the only compounding pharmacies in the country committed to conducting groundbreaking clinical trials.
Ongoing studies include:
• Topical Compounded Pain Creams and Pain Perception (TOPCAPP)
• Relieving Vasomotor Symptoms Effectively with Bio-identical Hormone Replacement Therapy: The REVERT Study
• Compounded Pain Preparation Absorption Study (ComPAS)
• Efficacy of Novel Drug Combinations for Relief of Psoriasis (ENDURE-Psoriasis)
• Strategic Compounding to Accelerate Scar Resolution After Surgery (SCARS)
These trials are registered on www.clinicaltrials.gov and are conducted in collaboration with East Coast Institute for Research, one of the most respected clinical research organizations in the country.
While most compounds never undergo clinical testing, Medimix is committed to being a change agent in the industry, leading the way by conducting studies that elucidate the efficacy, safety and cost-effectiveness of compounded medications. This commitment distinguishes Medimix from other compounders and affords fellows opportunities to work in uncharted areas. Acquired skills are applicable to positions in academia, industry and clinical settings, and separate candidates from other job applicants.
Fellows play an integral role in the research process at Medimix, learning how to a design a study, write a protocol, work with IRBs, execute the study, and present and publish the results.
How to Apply:
For more information about the Compounding Pharmacy Fellowship at Medimix Specialty Pharmacy, please email Ben Epstein, Pharm.D. at firstname.lastname@example.org.